1. Home
  2. STKL vs NUVB Comparison

STKL vs NUVB Comparison

Compare STKL & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • NUVB
  • Stock Information
  • Founded
  • STKL 1973
  • NUVB 2018
  • Country
  • STKL United States
  • NUVB United States
  • Employees
  • STKL N/A
  • NUVB N/A
  • Industry
  • STKL Precious Metals
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKL Basic Materials
  • NUVB Health Care
  • Exchange
  • STKL Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • STKL 631.4M
  • NUVB 679.9M
  • IPO Year
  • STKL N/A
  • NUVB N/A
  • Fundamental
  • Price
  • STKL $4.79
  • NUVB $1.76
  • Analyst Decision
  • STKL Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • STKL 2
  • NUVB 6
  • Target Price
  • STKL $9.50
  • NUVB $8.33
  • AVG Volume (30 Days)
  • STKL 773.5K
  • NUVB 3.1M
  • Earning Date
  • STKL 05-07-2025
  • NUVB 03-06-2025
  • Dividend Yield
  • STKL N/A
  • NUVB N/A
  • EPS Growth
  • STKL N/A
  • NUVB N/A
  • EPS
  • STKL N/A
  • NUVB N/A
  • Revenue
  • STKL $723,728,000.00
  • NUVB $7,873,000.00
  • Revenue This Year
  • STKL $9.79
  • NUVB $47.99
  • Revenue Next Year
  • STKL $7.58
  • NUVB $551.81
  • P/E Ratio
  • STKL N/A
  • NUVB N/A
  • Revenue Growth
  • STKL 15.48
  • NUVB N/A
  • 52 Week Low
  • STKL $4.83
  • NUVB $1.71
  • 52 Week High
  • STKL $8.11
  • NUVB $3.97
  • Technical
  • Relative Strength Index (RSI)
  • STKL 21.85
  • NUVB 36.74
  • Support Level
  • STKL $5.08
  • NUVB $1.85
  • Resistance Level
  • STKL $5.10
  • NUVB $2.04
  • Average True Range (ATR)
  • STKL 0.18
  • NUVB 0.16
  • MACD
  • STKL -0.00
  • NUVB -0.01
  • Stochastic Oscillator
  • STKL 4.48
  • NUVB 1.81

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for leading natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

Share on Social Networks: